In the last trading session, 0.65 million shares of the Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) were traded, and its beta was 3.64. Most recently the company’s share price was $0.47, and it changed around $0.04 or 10.06% from the last close, which brings the market valuation of the company to $24.53M. CDIO currently trades at a discount to its 52-week high of $1.77, offering almost -276.6% off that amount. The share price’s 52-week low was $0.19, which indicates that the current value has risen by an impressive 59.57% since then.

Cardio Diagnostics Holdings Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended CDIO as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight.

Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) trade information

Instantly CDIO has showed a green trend with a performance of 10.06% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.4820 on recent trading dayincreased the stock’s daily price by 2.49%. The company’s shares are currently down -48.70% year-to-date, but still up 4.37% over the last five days. On the other hand, Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) is 42.72% up in the 30-day period.

CDIO Dividends

Cardio Diagnostics Holdings Inc’s next quarterly earnings report is expected to be released in June.

VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024 . The former held 232.14 shares worth $0.11 million, making up 0.45% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held roughly 198.99 shares worth around $93606.0, which represents about 0.38% of the total shares outstanding.